Reaction
Skin Wound reporting signals
As of the last recalculation, Skin Wound appears in 1,643 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 23.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 29 | 23.9 | 23.9 |
| Sorafenib | 34 | 21.2 | 21.2 |
| Clobetasol Propionate | 10 | 12.3 | 12.3 |
| Regorafenib | 11 | 12.1 | 12.1 |
| Clobetasol Propionate Ointment Usp, 0.05% | 9 | 11.1 | 11.1 |
| Mupirocin | 11 | 10.4 | 10.4 |
| Mupirocin Calcium | 11 | 10.2 | 10.2 |
| Indapamide | 13 | 9.3 | 9.3 |
| Mesna Injection | 6 | 9.2 | 9.2 |
| Mesna | 6 | 9.1 | 9.1 |
| Ado-Trastuzumab Emtansine | 6 | 9.0 | 9.1 |
| Fexofenadine | 11 | 8.5 | 8.5 |
| Cetuximab | 14 | 5.7 | 5.7 |
| Methylphenidate | 11 | 4.8 | 4.8 |
| Belimumab | 12 | 4.8 | 4.8 |
| Secukinumab | 57 | 4.6 | 4.6 |
| Cabozantinib | 16 | 4.3 | 4.3 |
| Dupilumab | 145 | 4.1 | 4.1 |
| Nemolizumab-Ilto | 4 | 4.0 | 4.0 |
| Crisaborole | 3 | 4.0 | 4.0 |
| Abemaciclib | 6 | 3.8 | 3.8 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 9 | 3.7 | 3.7 |
| Osimertinib | 8 | 3.2 | 3.2 |
| Docosanol | 3 | 2.6 | 2.6 |
| Adapalene | 22 | 1.5 | 1.5 |
| Salicylic Acid | 4 | 1.0 | 1.0 |